Symtavision, into timing design and timing verification for embedded real-time systems, has launched SymTA/S 3.1 and TraceAnalyzer 3.1, major new versions of its seamlessly integrated system-level tools for planning, optimizing and verifying embedded real-time systems.
Targeted at automotive, aerospace, automation and other performance and safety-critical systems, SymTA/S 3.1 and TraceAnalyzer 3.1 include a wealth of new and enhanced features including new Scenario Management, a new FIBEX 3.1 import interface and improved Relative Deadline support. In addition, more than 50 functional improvements have been implemented at the request of customers including Audi, BMW, Bosch, Daimler and Fiat, among others.
Overview screenshot from SymTA/S 3.1
Overview screenshot from TraceAnalyzer 3.1
In SymTA/S 3.1 and TraceAnalyzer 3.1, the new Scenario Manager supports scenario-dependent scheduling parameters such as period and priority, as well as task execution time and CPU/bus speed. It is also fully user-customizable, allowing additional parameters to be covered. Support for the Field Bus Exchange (FIBEX) format has been updated, enabling the import of main system architecture and parameterization data in the latest FIBEX 3.1 file format. This enables the import of CAN and FlexRay configuration data including signals and function to ECU mappings. Improved Relative Deadline support enables deadline values to be automatically aligned whenever a period or task runtime changes.
Working ith its customers, Symtavision has also implemented more than 50 functional improvements in SymTA/S 3.1 and TraceAnalyzer 3.1. These include a decrease of up to 50 per cent in the memory requirements, enhanced Event Triggering analysis support, and new CAN-bus Load Variation Analysis enabling different load scenarios to be examined by varying message periods. Also included are FlexRay model check improvements, remote interfacing and scripting enhancements, as well as various charting, reporting, documentation and graphical user interface improvements.